Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV-Reference-Cited by-同舟云学术

Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV

Published:2021-06 Issue:6 Volume:8 Page:e317-e318
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Touizer Emma,Alrubayyi Aljawharah,Rees-Spear Chloe,Fisher-Pearson Natasha,Griffith Sarah A,Muir Luke,Pellegrino Pierre,Waters Laura,Burns Fiona,Kinloch Sabine,Rowland-Jones Sarah,Gupta Ravindra K,Gilson Richard,Peppa Dimitra,McCoy Laura E

Funder

Medical Research Council

National Institutes of Health

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference7 articles.

1. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV;Alrubayyi;bioRxiv,2021

2. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

3. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses;Sahin;Nature,2020

4. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies;Collier;Nature,2021

5. Safety and immunogenicity of the ChAdox1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection;Frater;SSRN,2021

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination;Russian journal of hematology and transfusiology;2024-08-18

2. Monoterpenes as Medicinal Agents: Exploring the Pharmaceutical Potential of p-Cymene, p-Cymenene, and γ-Terpinene;Acta Poloniae Pharmaceutica - Drug Research;2024-01-30

3. Factors associated with IgG titers against SARS-CoV-2 spike protein after second vaccination in people living with HIV controlled with anti-retroviral therapy;Journal of Infection and Chemotherapy;2024-01

4. Natural killer cell responses during SARS-CoV-2 infection and vaccination in people living with HIV-1;Scientific Reports;2023-11-03

5. Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV;iScience;2023-10